Systolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Diastolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Blood pressure target achievement · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
Educational or behavioural interventions for patients showed no clear difference in blood pressure target achievement compared with usual care (moderate certainty).
1 finding from 1 review
Medication adherence (continuous) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
LDL‐cholesterol · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
HbA1c (%) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Body‐mass index (BMI) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Death or dependence · adults with a brain arteriovenous malformation
Interventions probably leads to higher death or dependence compared with conservative management (moderate certainty).
1 finding from 1 review
Symptomatic intracerebral haemorrhage · adults with a brain arteriovenous malformation
Interventions probably leads to higher symptomatic intracerebral haemorrhage compared with conservative management (moderate certainty).
1 finding from 1 review
Epileptic seizure · adults with a brain arteriovenous malformation
Interventions showed no clear difference in epileptic seizure compared with conservative management (moderate certainty).
1 finding from 1 review
Symptomatic radiation necrosis ‒ not reported · adults with a brain arteriovenous malformation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ not reported · adults with a brain arteriovenous malformation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life and participation ‐ mobility and navigation intervention for not Pusher Syndrome (Analysis 1.2) · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression: meeting study criteria for depression at end of · people with depression after stroke
It is very uncertain whether pharmacological interventions changes depression: meeting study criteria for depression at end of… compared with placebo (very low certainty).
2 findings from 1 review
Depression: meeting study criteria for depression at end of · people with stroke
It is very uncertain whether pharmacological interventions (antidepressants) changes depression: meeting study criteria for depression at end treatment… compared with placebo (very low certainty).
1 finding from 1 review
Scoring above cut‐off points for a depressive disorder at end of treatment (Analysis 1.2) · people with stroke
1 finding from 1 review
Death Analysis 1.1
Interventions showed no clear difference in death Analysis 1.1 compared with control at end of intervention (low certainty).
1 finding from 1 review
Recurrent cardiovascular or cerebrovascular events Analysis 1.2
Interventions showed no clear difference in recurrent cardiovascular or cerebrovascular events Analysis 1.2 compared with control at end of intervention (low certainty).
1 finding from 1 review
Adverse events
Interventions showed no clear difference in adverse events compared with control at end of intervention (low certainty).
1 finding from 1 review